On June 23, 2023, Margaret Koziel, M.D., who has served as the Company’s Senior Vice President and Chief Medical Officer, notified the Company of her resignation from the Company, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Axcella Health Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).
Exchange
nasdaq
Notice
delisting notice
Deficiency
minimum bid price
Rules
5450(a)(1)
Exact text from the filing
June 29, 2023, Axcella Health Inc., (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) as of June 28, 2023, the Company would be delisted at the opening of business on July 10, 2023 unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”) to address the deficiencies and present a plan to regain compliance. The Company plans to timely request a hearing before the
Margaret Koziel resigned as Senior Vice President and Chief Medical Officer at Axcella Health Inc..
Action
resigned
Role
Senior Vice President and Chief Medical Officer
Exact text from the filing
On June 23, 2023, Margaret Koziel, M.D., who has served as the Company’s Senior Vice President and Chief Medical Officer, notified the Company of her resignation from the Company, effective immediately.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.